Aandelen in “Biotechnologie”

Aandeel Datum Koers Evolutie
vlag Ultragenyx Pharmaceutical Inc. 31/10 34,600 USD
-1,62% 		-1,62%
vlag uniQure N.V. 31/10 67,690 USD
-0,25% 		-0,25%
vlag UroGen Pharma Ltd 30/10 19,850 USD
+0,35% 		+0,35%

Nieuws over “Biotechnologie”

31/10 · Cellectis to Report Third Quarter Financial Results on November 7, 2025 · Persbericht

31/10 · Cellectis to Report Third Quarter Financial Results on November 7, 2025 · Persbericht

31/10 · AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND · Persbericht

31/10 · AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025 · Persbericht

31/10 · Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast · Persbericht

31/10 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 17, 2025 in Cytokinetics, Incorporated Lawsuit - CYTK · Persbericht

31/10 · Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025 - SVRA · Persbericht

31/10 · PTC Therapeutics to Participate at Upcoming Investor Conferences · Persbericht

31/10 · IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) · Persbericht

31/10 · NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth · Persbericht

30/10 · Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London · Persbericht

30/10 · DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors · Persbericht

30/10 · Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 · Persbericht

30/10 · Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development · Persbericht

30/10 · Galapagos kondigt wijzigingen aan in de Raad van Bestuur om de strategische focus op business development te versnellen · Persbericht

30/10 · GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market · Persbericht

30/10 · Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 · Persbericht

30/10 · Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia · Persbericht

30/10 · NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression · Persbericht

30/10 · Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 · Persbericht

30/10 · REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program · Persbericht

Mijn selecties